| 1. | Circular Memo for ensuring the use of authentic Indian Pharmacopoeia, IP Reference Standards IPRS and impurity standards for quality testing of drugs. |
| 2. | Circular issued regarding certain instructions on sale of Oxytocin |
| 3. | DCA - Circular on Risk-based Sampling |
| 4. | DCA - Advisory Procurement and testing of the raw materials Glycerin and Propylene Glycol by the Cough Syrup manufacturers |
| 5. | Classification of Medical Devices - List of Medical Devices, IVDs along with their risk class under provisions of sub-rule 1 Rule 4 of the Medical Devices Rules, 2017 |
| 6. | Medical Devices Rules 2017 |
| 7. | List of Notified Bodies registered with CDSCO under Medical Devices Rules. |
| 8. | Grouping guidelines for Medical Devices applications |
| 9. | FAQs on Medical Devices Rules |
| 10. | Notice regarding List of Reference Products for conduct of BE Study for Oral Solid Dosage Forms containing BCS Class II and Class IV drugs |
| 11. | Fixed Dose Combinations FDCs approved by DCG (I) since 1961 to 31st December 2019 |
| 12. | Prohibition of certain FDCs appeared in the list of 294 FDCs, under Section 26A |
| 13. | GUIDELINES FOR TAKING ACTION ON SAMPLES OF DRUGS DECLARED SPURIOUS OR NOT OF STANDARD QUALITY |
| 14. | Standards for Blood Banks and Blood Transfusion Services |
| 15. | Guideline issued by CDSCO for uploading manufacturing sites and formulation data on the SUGAM Portal by manufacturers |
| 16. | Procedure for submission of cough syrups to be exported by manufacturer, exporter directly to Central, NABL accredited state testing laboratories for testing purpose. |
| 17. | Instructions issued to Drugs Inspectors regarding regulation of sale and distribution of N95 Masks, PPE, Hand Sanitizers and related medicines. |
| 18. | Guidance Document and Steps to be followed by the manufcaturers/importers for registration of Non-notified Medical Devices. |
| 19. | Cosmetics Rules 2020 |
| 20. | Implementation of regulation of pre shipment document verification, physical inspection, QC testing, issuance of CRIA for pharmaceuticals to be exported to The Gambia by Medicines Control Agency |
| 21. | Circular issued regarding strict enforcement of testing of Aluminum in Purified Water, raw materials used for preparation of Dialysis Solutions and in the final product Haemodialysis Solutions. |
| 22. | Circular regarding procedure to be adopted in the investigation and recall of the drugs declared as NSQ or Spurious |
| 23. | Circular regarding Rule 84AB for uploading data of drug manufacturing facilities and approved drug formulations on SUGAM portal |
| 24. | Circular of DCGI regarding modalities of Joint Inspection for Grant of Manufacturing Licence |
| 25. | GSR 1337E dated 27-10-2017 regarding retention of licences, omission of renewal |
| 26. | Consequential Amendments to GSR 1337E Gazette Notification |
| 27. | New Drugs and Clinical Trial Rules 2019 |
| 28. | FAQs on New Drugs and Clinical Trial Rules 2019 |
Designed, Developed and Hosted by National Informatics Centre, Hyderabad.
Content owned, maintained and updated by Department of Drugs Control Administration, Government of Telangana
